Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 1
1995 2
1997 2
1998 1
1999 3
2000 4
2001 1
2002 2
2003 2
2004 1
2005 4
2006 4
2007 5
2008 4
2010 3
2011 9
2012 5
2013 6
2014 9
2015 5
2016 7
2017 8
2018 7
2019 6
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

97 results
Results by year
Filters applied: . Clear all
Page 1
Primary Sclerosing Cholangitis: What the Gastroenterologist and Hepatologist Needs to Know.
Gossard AA, Gores GJ. Gossard AA, et al. Clin Liver Dis. 2017 Nov;21(4):725-737. doi: 10.1016/j.cld.2017.06.004. Epub 2017 Jul 25. Clin Liver Dis. 2017. PMID: 28987259 Review.
Primary sclerosing cholangitis (PSC) is a chronic, idiopathic biliary tract disease characterized by segmental strictures. The disease is progressive with no proven treatments and may eventually lead to cirrhosis and end-stage liver disease. Abrupt changes in
Primary sclerosing cholangitis (PSC) is a chronic, idiopathic biliary tract disease characterized by segmental strictur
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
Banales JM, Iñarrairaegui M, Arbelaiz A, Milkiewicz P, Muntané J, Muñoz-Bellvis L, La Casta A, Gonzalez LM, Arretxe E, Alonso C, Martínez-Arranz I, Lapitz A, Santos-Laso A, Avila MA, Martínez-Chantar ML, Bujanda L, Marin JJG, Sangro B, Macias RIR. Banales JM, et al. Hepatology. 2019 Aug;70(2):547-562. doi: 10.1002/hep.30319. Epub 2019 Feb 14. Hepatology. 2019. PMID: 30325540 Free PMC article.
Because primary sclerosing cholangitis (PSC) is a risk factor for CCA, serum metabolic profiles of PSC and CCA have also been compared. ...Several metabolites presented high diagnostic value for iCCA versus control, HCC versus control, and PSC versus control, …
Because primary sclerosing cholangitis (PSC) is a risk factor for CCA, serum metabolic profiles of PSC and CCA have als …
Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
Boyd S, Mustonen H, Tenca A, Jokelainen K, Arola J, Färkkilä MA. Boyd S, et al. Scand J Gastroenterol. 2017 Feb;52(2):242-249. doi: 10.1080/00365521.2016.1250281. Epub 2016 Nov 3. Scand J Gastroenterol. 2017. PMID: 27806633
OBJECTIVE: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease leading to bile duct strictures and fibrosis, and predisposing to cholangiocarcinoma (CCA). ...CONCLUSIONS: PSC patients with advanced bile duct disease and elevated liver …
OBJECTIVE: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease leading to bile duct strictures …
Pathogenesis, diagnosis, and management of cholangiocarcinoma.
Rizvi S, Gores GJ. Rizvi S, et al. Gastroenterology. 2013 Dec;145(6):1215-29. doi: 10.1053/j.gastro.2013.10.013. Epub 2013 Oct 15. Gastroenterology. 2013. PMID: 24140396 Free PMC article. Review.
Cancer Risk and Surveillance in Primary Sclerosing Cholangitis.
Folseraas T, Boberg KM. Folseraas T, et al. Clin Liver Dis. 2016 Feb;20(1):79-98. doi: 10.1016/j.cld.2015.08.014. Epub 2015 Oct 21. Clin Liver Dis. 2016. PMID: 26593292 Review.
Primary sclerosing cholangitis (PSC) is a chronic, progressive disease characterized by inflammatory and fibrosing strictures of the biliary tree. ...
Primary sclerosing cholangitis (PSC) is a chronic, progressive disease characterized by inflammatory and fibrosing stri
Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline.
Aabakken L, Karlsen TH, Albert J, Arvanitakis M, Chazouilleres O, Dumonceau JM, Färkkilä M, Fickert P, Hirschfield GM, Laghi A, Marzioni M, Fernandez M, Pereira SP, Pohl J, Poley JW, Ponsioen CY, Schramm C, Swahn F, Tringali A, Hassan C. Aabakken L, et al. Endoscopy. 2017 Jun;49(6):588-608. doi: 10.1055/s-0043-107029. Epub 2017 Apr 18. Endoscopy. 2017. PMID: 28420030 Free article.
1 ESGE/EASL recommend that, as the primary diagnostic modality for PSC, magnetic resonance cholangiography (MRC) should be preferred over endoscopic retrograde cholangiopancreatography (ERCP).Moderate quality evidence, strong recommendation. 2 ESGE/EASL suggest that ERCP c …
1 ESGE/EASL recommend that, as the primary diagnostic modality for PSC, magnetic resonance cholangiography (MRC) should be preferred …
Primary sclerosing cholangitis: diagnosis, prognosis, and management.
Singh S, Talwalkar JA. Singh S, et al. Clin Gastroenterol Hepatol. 2013 Aug;11(8):898-907. doi: 10.1016/j.cgh.2013.02.016. Epub 2013 Feb 27. Clin Gastroenterol Hepatol. 2013. PMID: 23454027 Free PMC article. Review.
Primary sclerosing cholangitis (PSC) is a chronic immune-mediated disease of the liver of unclear etiology, characterized by chronic inflammation and fibrosis of bile ducts. ...
Primary sclerosing cholangitis (PSC) is a chronic immune-mediated disease of the liver of unclear etiology, characteriz
Cholangiocarcionoma and primary sclerosing cholangitis: the answer lies within.
Shah RJ. Shah RJ. Gastrointest Endosc. 2014 May;79(5):780-2. doi: 10.1016/j.gie.2013.12.022. Gastrointest Endosc. 2014. PMID: 24721627 No abstract available.
Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.
Ahrendt SA, Pitt HA, Nakeeb A, Klein AS, Lillemoe KD, Kalloo AN, Cameron JL. Ahrendt SA, et al. J Gastrointest Surg. 1999 Jul-Aug;3(4):357-67; discussion 367-8. doi: 10.1016/s1091-255x(99)80051-1. J Gastrointest Surg. 1999. PMID: 10482687
Recently serum carcinoembryonic antigen and carbohydrate antigen 19-9 (CA 19-9) levels have been reported to improve diagnostic accuracy in patients with cholangiocarcinoma and primary sclerosing cholangitis. . …
Recently serum carcinoembryonic antigen and carbohydrate antigen 19-9 (CA 19-9) levels have …
Longitudinal analysis of CA19-9 reveals individualised normal range and early changes before development of biliary tract cancer in patients with primary sclerosing cholangitis.
Wannhoff A, Brune M, Knierim J, Weiss KH, Rupp C, Gotthardt DN. Wannhoff A, et al. Aliment Pharmacol Ther. 2019 Mar;49(6):769-778. doi: 10.1111/apt.15146. Epub 2019 Jan 27. Aliment Pharmacol Ther. 2019. PMID: 30687954 Free article.
BACKGROUND: Primary sclerosing cholangitis is associated with an increased risk of biliary tract cancer. Carbohydrate antigen 19-9 (CA19-9) can be used to screen for these malignancies. AIM: To perform a longitudinal analysi …
BACKGROUND: Primary sclerosing cholangitis is associated with an increased risk of biliary tract cancer. Carbohydrate …
97 results
Jump to page
Feedback